BROWSE ALL ARTICLES BY TOPIC
Articles by Section - Department: Metrics/Profiles in Rheumatology
Listing articles 1 to 10 of 26
Departments: CORRONA Team Provides Data-Based Tool to Address Rheumatology's Questions
The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit
Departments: Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology
Career marked by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis
Departments: Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances
Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.
Audio: Epidemiologist Discusses Osteoarthritis Among Various Countries and Ethnic Groups
David T. Felson, MD, MPH, discusses his Beijing study that compared knee, hip, and hand osteoarthritis among Chinese to Caucasians in the Framingham study and the UCSF Study of Osteoporotic Fractures.
Departments: A Passion for Multidisciplinary Collaboration
Through teamwork, David T. Felson, MD, MPH, has advanced understanding and treatment of rheumatic diseases
Departments: It's All About the Patient
We always knew she was going a thousand miles an hour,” recalls Kenneth Grant, MD, professor of medicine at Touro University in Nevada, of his former mentor Evelyn V. Hess, MD, distinguished professor emerita and founder and former chief of the division of immunology, allergy, and rheumatology at the University of Cincinnati Medical School. Adds Michael Luggen, MD, another former fellow of Dr. Hess and professor of clinical medicine in the Division at the University of Cincinnati: “She had...
Departments: A Unique Structure for Tackling Psoriatic Disease
On August 14, 2003, thought leaders in rheumatology and dermatology were set to arrive at the New York Marriott Marquis to start work on a collaborative infrastructure to advance the understanding, diagnosis, and treatment of cutaneous psoriasis (PsC) and psoriatic arthritis (PsA). The meeting was the culmination of nearly two years of work on the part of rheumatology and dermatology leaders, including Oliver FitzGerald, Dafna Gladman, Philip Helliwell, Arthur Kavanaugh, Gerald Krueger, Philip Mease, Chris...
Departments: He Taught Us to Always Go Deeper
In the mid-1960s, a young physician at Rockefeller University in New York City was caring for a young girl with the debilitating autoimmune disorder systemic lupus erythematosus (SLE), as had other rheumatology colleagues before him. As a research fellow, he was also putting in long hours performing experiments using her sera to detect precipitating antibodies against cellular and tissue antigens. Using the Ouchterlony agar diffusion method, he and his mentor, Henry Kunkel, MD, observed that a certain...
Departments: An 'Idea Factory' Focused on Patient Care
For a person who claims she “fell” into rheumatology, Patricia “Trish” Cornell, BSc, has influenced treatment processes in a remarkably short time. Cornell, the senior rheumatology practitioner at Poole Hospital National Health Service (NHS) Foundation Trust in Dorset, England, joined the rheumatology unit there in 1998. Since that time, she’s been instrumental in organizing the outpatient teams that manage the day-to-day care of patients with inflammatory arthritis. She...
Departments: "A Common Language for SPONDYLOARTHRITIS"
Fifteen years ago, a small group of academic rheumatologists began meeting to discuss a common clinical interest in ankylosing spondylitis (AS). Their work launched a dialogue that has had an enormous impact on the field of rheumatology—and on the lives of people with AS. A disease with little in the way of common measurement tools, AS soon gained center stage in rheumatology as treatment with tumor necrosis factor (TNF) inhibitors showed dramatic results for this previously intractable condition....
